Free tool
Drug Trial Radar: Ophthalmology
Last checked: Nov 20, 2026Latest source record: Feb 6, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
1
Not yet recruiting, industry sponsors, Ophthalmology, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed188
1 trial
Showing 1 to 1, recently updated first.
- Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial SpondyloarthritisNot yet recruiting
CARE ARTHRITIS LTD.Industry
NCT07018206 · 200 participants (planned) · Start May 2026 · Primary completion May 2027
Drug: Upadacitinib 15 MG [Rinvoq] · For: Axial Spondylarthritis (axSpA)
Sites: Philadelphia, Pennsylvania
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.